Linklaters advised OmnigenicsAI Corp, a precision medicine company incubated by Bioceres Group PLC, on a definitive Business Combination Agreement with APx Acquisition Corp. I (NASDAQ: APXI), a publicly traded special purpose acquisition company, and MultiplAI Health Ltd, a UK-based AI-enabled preventive medicine company, that, upon closing, would result in OmnigenicsAI becoming a publicly listed company. The deal values OmnigenicsAI and MultiplAI at a combined enterprise value of approximately $340 million at signing, and the transaction is expected to close mid-year, subject to the approval of APx's shareholders and other customary closing conditions.
The strategic combination creates a global AI-driven genomics company focused on providing secure, precise, and reliable biological data. The integration of AI with precision medicine enables the interpretation of complex genomic data at an unprecedented scale, allowing for the delivery of highly personalized health insights, and clinical and therapeutic guidance.
Linklaters’ cross-border team advising on this transaction was led by Corporate Partners
Matthew Poulter in São Paulo and
Pierre-Emmanuel Perais in New York, Tax Partner
Gabriel Grossman in New York, and Executive Compensation and Employee Benefits Partner
Andrew Gaines in New York.
Spanning New York, Washington, D.C., and São Paulo the team also included corporate support from Partner
Clara Pang, Managing Associate Marcelo Lopes, and Associates
Thomas Lemouche,
Damini Bhatnagar,
Caroline Aguiar, and Andreina Lamas; tax support from Partner
Michelle Lo, Counsel
Sean McKeever, and Associates
Erika Jensen and
Young Jin Kim; antitrust and foreign investment support from Partner
Antonia Sherman; and TMT support from Senior Associate
Caitlin Potratz Metcalf.
In London, the team also included tax support from Partner
Jamie Coomber and Associate Robert Russell, and antitrust and foreign investment support from Partner
Bruce Kilpatrick.
In Brussels, the team included TMT support from Managing Associate
Tom De Coster and Associate Florence Seghers.
In Warsaw, the team included corporate support from Managing Associate
Michal Szperzynski.
This transaction follows a flurry of high-profile corporate deal activity for Linklaters in the U.S., having recently advised
The Chefs’ Warehouse, Inc. on its Engagement with and Entering into a Cooperation Agreement with Legion Partners an Activist Investment Manager,
Elia Group on its agreement to acquire stake in energyRe Giga, and
Getir on its acquisition of FreshDirect.
For additional information on the transaction, read the
APx Acquisition Corp. I press release.
About Linklaters
Linklaters is a 185-year-old leading global law firm with over 3,100 lawyers across 31 offices in 21 countries. We combine legal expertise with a collaborative and innovative approach to help clients navigate constantly evolving markets and regulatory environments, pursuing opportunities and managing risk worldwide. In order to offer our clients the highest quality advice, our lawyers across three divisions — Corporate; Litigation, Arbitration, and Investigations; and Finance — specialize in industry sectors as well as practice areas.